Enter your login e-mail to the account
Search
Search parameters
Search results
- New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium )
- New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Is age the limitation of metastatic treatment prostate cancer?
MUDr. Jana Katolická, Ph.D.
(5/2018, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles ) - Current treatment management of non-metastatic castration-resistant prostate cancer
MUDr. Nikol Rušarová, MUDr. Hana Študentová, Ph.D.
(1/2020, Review articles ) - Treatment of non-metastatic castration-resistant prostate cancer
MUDr. Ivo Kocák, Ph.D.
(4/2020, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles )
- Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of bone metastases in castration resistant prostate cancer – current view
doc. MUDr. Jozef Marenčák, PhD.
(3/2015, Review articles ) - Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Treatment of patient with metastatic castrate refractory prostate cancer after androgen deprivation therapy failure
MUDr. Jozef Babeľa, PhD.
(S1/2019, Case reports ) - Death following brain metastases evolvement in patient with metastatic castration resistant adenocarcinoma of prostate treated by enzalutamide with low level PSA
MUDr. Roman Tomaškin, PhD.
(S1/2019, Case reports ) - Treatment of metastatic castrate-resistant prostate cancer with enzalutamide
MUDr. Klaudia Gočárová, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
MUDr. Andrej Rosík, MUDr. Ladislav Slobodník
(S1/2019, Case reports ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Treatment of enzalutamide in the therapy of metastatic castration-resistant prostate cancer in postchemoindication
MUDr. Alexandra Szabová
(S1/2020, Case reports ) - Treatment of patient with metastatic prostate cancer – from sensitive to castration resistant disease – case report
MUDr. Vladimír Lenko, PhD., FEBU
(S1/2020, Case reports ) - Správa z XXI. košických chemoterapeutických dní
MUDr. Jana Jankurová
(1/2018, Events ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles )
- Nové liečivá v EÚ registrované v roku 2013 (II.)
PharmDr. Peter Stanko
(1/2014, New drugs )